Leukemia, Myeloma and Lymphoma The MBRCC Myeloma & Lymphoma Service is the first and only comprehensive, multidisciplinary program in the state of West Virginia designed to provide individualized, state-of-the-art diagnosis and treatment for multiple myeloma, chronic lymphocytic leukemia, Hodgkin and non-Hodgkin lymphomas. The guiding principles of our service are quality, innovation, research and service. Multidisciplinary care involves the collaboration between all healthcare professionals. Working together allows experts from different departments to come together to provide the most cutting edge cancer treatment and management services. The Myeloma & Lymphoma Service is dedicated to provide cutting edge, state-of-art therapies for Myeloma and Lymphoma patients in an evidence-based, patient-centered manner. The Myeloma & Lymphoma Service at WVU consists of physicians with nationally recognized expertise in myeloma and lymphoma, and a group of experienced physician assistants, nurse practitioners, nurse clinicians, social workers, financial experts and clinical trial specialists. This team of specialists, along with other healthcare workers, work together to create an individualized, tailored treatment plan. Treatments offered at WVU Myeloma & Lymphoma Service in addition to standard chemo- and radiotherapies, include; novel immunotherapies, chemoimmunotherapies, radio-immunotherapies, novel targeted oral agents, cryotherapies, kyphoplasty and gene-therapy. Our Myeloma & Lymphoma Service boosts the most robust clinical trials program in the state of West Virginia, striving to bring novel, safer and more effective therapies to myeloma and lymphoma patients, with one focused goal of defeating cancer.